FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2152338271> ?p ?o ?g. }

• W2152338271 endingPage "3094" @default.
• W2152338271 startingPage "3087" @default.
• W2152338271 abstract "Aldosterone and angiotensin (Ang) II both may cause organ damage. Circulating aldosterone is produced in the adrenals; however, local cardiac synthesis has been reported. Aldosterone concentrations depend on the activity of aldosterone synthase (CYP11B2). We tested the hypothesis that reducing aldosterone by inhibiting CYP11B2 or by adrenalectomy (ADX) may ameliorate organ damage. Furthermore, we investigated how much local cardiac aldosterone originates from the adrenal gland.We investigated the effect of the CYP11B2 inhibitor FAD286, losartan, and the consequences of ADX in transgenic rats overexpressing both the human renin and angiotensinogen genes (dTGR). dTGR-ADX received dexamethasone and 1% salt. Dexamethasone-treated dTGR-salt served as a control group in the ADX protocol. Untreated dTGR developed hypertension and cardiac and renal damage and had a 40% mortality rate (5/13) at 7 weeks. FAD286 reduced mortality to 10% (1/10) and ameliorated cardiac hypertrophy, albuminuria, cell infiltration, and matrix deposition in the heart and kidney. FAD286 had no effect on blood pressure at weeks 5 and 6 but slightly reduced blood pressure at week 7 (177+/-6 mm Hg in dTGR+FAD286 and 200+/-5 mm Hg in dTGR). Losartan normalized blood pressure during the entire study. Circulating and cardiac aldosterone levels were reduced in FAD286 or losartan-treated dTGR. ADX combined with dexamethasone and salt treatment decreased circulating and cardiac aldosterone to barely detectable levels. At week 7, ADX-dTGR-dexamethasone-salt had a 22% mortality rate compared with 73% in dTGR-dexamethasone-salt. Both groups were similarly hypertensive (190+/-9 and 187+/-4 mm Hg). In contrast, cardiac hypertrophy index, albuminuria, cell infiltration, and matrix deposition were significantly reduced after ADX (P<0.05).Aldosterone plays a key role in the pathogenesis of Ang II-induced organ damage. Both FAD286 and ADX reduced circulating and cardiac aldosterone levels. The present results show that aldosterone produced in the adrenals is the main source of cardiac aldosterone." @default.
• W2152338271 created "2016-06-24" @default.
• W2152338271 creator A5004569891 @default.
• W2152338271 creator A5012825132 @default.
• W2152338271 creator A5017346227 @default.
• W2152338271 creator A5031165791 @default.
• W2152338271 creator A5043072482 @default.
• W2152338271 creator A5062049504 @default.
• W2152338271 creator A5066517355 @default.
• W2152338271 creator A5066875692 @default.
• W2152338271 creator A5074348628 @default.
• W2152338271 creator A5078018907 @default.
• W2152338271 creator A5079089312 @default.
• W2152338271 creator A5079589473 @default.
• W2152338271 creator A5081811761 @default.
• W2152338271 creator A5091554690 @default.
• W2152338271 date "2005-06-14" @default.
• W2152338271 modified "2023-10-13" @default.
• W2152338271 title "Aldosterone Synthase Inhibitor Ameliorates Angiotensin II–Induced Organ Damage" @default.
• W2152338271 cites W1971933960 @default.
• W2152338271 cites W1973794764 @default.
• W2152338271 cites W1976853286 @default.
• W2152338271 cites W1983323298 @default.
• W2152338271 cites W1998583802 @default.
• W2152338271 cites W2001171328 @default.
• W2152338271 cites W2009805500 @default.
• W2152338271 cites W2017884988 @default.
• W2152338271 cites W2037758253 @default.
• W2152338271 cites W2049642674 @default.
• W2152338271 cites W2056038215 @default.
• W2152338271 cites W2065279969 @default.
• W2152338271 cites W2072112557 @default.
• W2152338271 cites W2096111588 @default.
• W2152338271 cites W2102041759 @default.
• W2152338271 cites W2126174661 @default.
• W2152338271 cites W2131750073 @default.
• W2152338271 cites W2136714451 @default.
• W2152338271 cites W2140015750 @default.
• W2152338271 cites W2152094259 @default.
• W2152338271 cites W2153585291 @default.
• W2152338271 cites W2154554488 @default.
• W2152338271 cites W2156417161 @default.
• W2152338271 cites W2157756663 @default.
• W2152338271 cites W2163709605 @default.
• W2152338271 cites W2167590375 @default.
• W2152338271 cites W2168453807 @default.
• W2152338271 cites W2323458614 @default.
• W2152338271 cites W2505945435 @default.
• W2152338271 doi "https://doi.org/10.1161/circulationaha.104.521625" @default.
• W2152338271 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15939810" @default.
• W2152338271 hasPublicationYear "2005" @default.
• W2152338271 type Work @default.
• W2152338271 sameAs 2152338271 @default.
• W2152338271 citedByCount "167" @default.
• W2152338271 countsByYear W21523382712012 @default.
• W2152338271 countsByYear W21523382712013 @default.
• W2152338271 countsByYear W21523382712014 @default.
• W2152338271 countsByYear W21523382712015 @default.
• W2152338271 countsByYear W21523382712016 @default.
• W2152338271 countsByYear W21523382712017 @default.
• W2152338271 countsByYear W21523382712018 @default.
• W2152338271 countsByYear W21523382712019 @default.
• W2152338271 countsByYear W21523382712021 @default.
• W2152338271 countsByYear W21523382712022 @default.
• W2152338271 countsByYear W21523382712023 @default.
• W2152338271 crossrefType "journal-article" @default.
• W2152338271 hasAuthorship W2152338271A5004569891 @default.
• W2152338271 hasAuthorship W2152338271A5012825132 @default.
• W2152338271 hasAuthorship W2152338271A5017346227 @default.
• W2152338271 hasAuthorship W2152338271A5031165791 @default.
• W2152338271 hasAuthorship W2152338271A5043072482 @default.
• W2152338271 hasAuthorship W2152338271A5062049504 @default.
• W2152338271 hasAuthorship W2152338271A5066517355 @default.
• W2152338271 hasAuthorship W2152338271A5066875692 @default.
• W2152338271 hasAuthorship W2152338271A5074348628 @default.
• W2152338271 hasAuthorship W2152338271A5078018907 @default.
• W2152338271 hasAuthorship W2152338271A5079089312 @default.
• W2152338271 hasAuthorship W2152338271A5079589473 @default.
• W2152338271 hasAuthorship W2152338271A5081811761 @default.
• W2152338271 hasAuthorship W2152338271A5091554690 @default.
• W2152338271 hasBestOaLocation W21523382711 @default.
• W2152338271 hasConcept C126322002 @default.
• W2152338271 hasConcept C134018914 @default.
• W2152338271 hasConcept C198710026 @default.
• W2152338271 hasConcept C2776069600 @default.
• W2152338271 hasConcept C2778525890 @default.
• W2152338271 hasConcept C2780087391 @default.
• W2152338271 hasConcept C2780091579 @default.
• W2152338271 hasConcept C2780249997 @default.
• W2152338271 hasConcept C2780288358 @default.
• W2152338271 hasConcept C2780401358 @default.
• W2152338271 hasConcept C2908929049 @default.
• W2152338271 hasConcept C71924100 @default.
• W2152338271 hasConcept C84393581 @default.
• W2152338271 hasConceptScore W2152338271C126322002 @default.
• W2152338271 hasConceptScore W2152338271C134018914 @default.
• W2152338271 hasConceptScore W2152338271C198710026 @default.
• W2152338271 hasConceptScore W2152338271C2776069600 @default.

• next